Dr. Mohamad Hadi Khafaja, MD

Dr. Khafaja practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Khafaja's NPI, 1780867119, was assigned on December 7, 2007. Dr. Khafaja graduated from University of Medicine Sci In Poznan, Faculty Ii in 2006. Dr. Khafaja holds California license A115892.

Dr. Khafaja's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Khafaja's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Khafaja is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Khafaja to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khafaja practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Khafaja's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Khafaja is board certified in geriatric psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Khafaja's licenses on file in 2 states: California and New Mexico.

Dmand AI lists adjustment disease, bipolar disorder, depression, psychological distress, psychoses and schizophrenia among the conditions Dr. Khafaja treats.

CMS data shows 2,194 Medicare services from Dr. Khafaja across 6 procedure codes in 2024, for 172 Medicare patients. Medicare paid $194,905 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 172 Medicare patients who saw Dr. Khafaja in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have anxiety, and 75% have high blood pressure. 81% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khafaja's median patient age at 62, with 50% women.

In 2024, Dr. Khafaja wrote 448 Medicare Part D claims for 107 patients. 95% of them were for generic drugs. CMS names the drug for 183 of them, across 9 drugs with 11 or more claims each, at $3,076 in total drug cost. In 2022, CMS named 54 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Khafaja for performance year 2024, reported as part of a group. Dr. Khafaja accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Khafaja, published from 2013 to 2020. 2017 was the busiest year, with 2. The most frequent topics are Cross-Over Studies, Deep Brain Stimulation and Electroconvulsive Therapy. Dr. Khafaja has published most often in J ECT. Dr. Khafaja's most frequent co-authors are Christopher C. Abbott, MD, Amanda L. Deligtisch, MD and Davin K. Quinn, MD.

CMS Open Payments shows 1 general payment to Dr. Khafaja from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Alkermes, Inc. paid the most, $107.

Dr. Khafaja graduated from University of Medicine Sci In Poznan, Faculty Ii in 2006.

Dr. Khafaja is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.